Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR-TRC-14004079Phase 4Not yet recruiting
Phase 4, randomised, open-label trial comparing Propess with Amniotomy plus oxytocin (2 arms). Primary endpoint: Failed induction rate. Planned start Sep 2014; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR-TRC-14004079.